ADAMS STREET PARTNERS LLC Quant / Systematic

CIK: 0001193586 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $112,818 (100.0% shares, 0.0% debt)

Holdings (6)

RMNI Rimini Street, Inc. 55.8%

Value ($000) $62,920 Shares 23,565,433 Est. Cost $8.44 Unrealized -75.8%

CRVS Corvus Pharmaceuticals, Inc. 15.5%

Value ($000) $17,525 Shares 3,275,616 Est. Cost $13.47 Unrealized -44.6%

MLYS Mineralys Therapeutics, Inc. 12.3%

Value ($000) $13,908 Shares 1,129,807 Est. Cost $16.83 Unrealized -22.3%

PAY Paymentus Holdings, Inc. 7.9%

Value ($000) $8,953 Shares 274,039 Est. Cost $29.72 Unrealized 0.0%

PVLA Palvella Therapeutics, Inc. 4.4%

Value ($000) $4,916 Shares 409,666 Est. Cost $15.71 Unrealized 0.0%

— Vacasa, Inc. 4.1%

Value ($000) $4,597 Shares 938,221 Est. Cost $6.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RMNI	Rimini Street, Inc.	23,565,433	$62,920	55.8%	$8.44	-75.8%	Common	76674Q107
CRVS	Corvus Pharmaceuticals, Inc.	3,275,616	$17,525	15.5%	$13.47	-44.6%	Common	221015100
MLYS	Mineralys Therapeutics, Inc.	1,129,807	$13,908	12.3%	$16.83	-22.3%	Common	603170101
PAY	Paymentus Holdings, Inc.	274,039	$8,953	7.9%	$29.72	0.0%	Common- Class A	70439P108
PVLA	Palvella Therapeutics, Inc.	409,666	$4,916	4.4%	$15.71	0.0%	Common	697947109
—	Vacasa, Inc.	938,221	$4,597	4.1%	$6.75	—	Common- Class A	91854V107